Tomas Norman Dam
- Immunology top 5%
- Dermatology top 2%
- Molecular Biology
- Oncology
- Rheumatology
- Co-authors
- Lone SkovFrederik Dagnæs‐HansenMarleen M. Voorhorst‐OginkJanine SchuurmanFrank J. BeurskensJørgen RygaardOle BaadsgaardJan G. J. van de Winkel
- Topics
- Psoriasis: Treatment and Pathogenesis (12 papers)Dermatology and Skin Diseases (6 papers)Health Systems, Economic Evaluations, Quality of Life (4 papers)
- Partner nations
- DenmarkUnited StatesNetherlands
In The Last Decade
Tomas Norman Dam
25 papers receiving 684 citations
Peers
Comparison fields: 5 of 79
- Immunology 491
- Dermatology 180
- Molecular Biology 148
- Oncology 116
- Rheumatology 69
Countries citing papers authored by Tomas Norman Dam
This map shows the geographic impact of Tomas Norman Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Norman Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Norman Dam more than expected).
Fields of papers citing papers by Tomas Norman Dam
This network shows the impact of papers produced by Tomas Norman Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Norman Dam. The network helps show where Tomas Norman Dam may publish in the future.
Co-authorship network of co-authors of Tomas Norman Dam
This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Norman Dam. A scholar is included among the top collaborators of Tomas Norman Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Norman Dam. Tomas Norman Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 12 | |
| 5 | 26 | |
| 6 | 29 | |
| 7 | 6 | |
| 8 | 14 | |
| 9 | Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases. | 2 |
| 10 | 44 | |
| 11 | 20 | |
| 12 | 7 | |
| 13 | 62 | |
| 14 | 13 | |
| 15 | 11 | |
| 16 | 14 | |
| 17 | 23 | |
| 18 | 51 | |
| 19 | 138 | |
| 20 | 144 |
About Tomas Norman Dam
Tomas Norman Dam is a scholar working on Dermatology, Immunology and Anatomy, having authored 25 papers that have together received 710 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Immunology (491 citations), Dermatology (180 citations) and Immunology and Allergy (36 citations). Tomas Norman Dam has collaborated with scholars based in Denmark, United States and Netherlands. Frequent co-authors include Lone Skov, Frederik Dagnæs‐Hansen, Marleen M. Voorhorst‐Ogink, Janine Schuurman, Frank J. Beurskens, Jørgen Rygaard, Ole Baadsgaard, Jan G. J. van de Winkel, Marc A. van Dijk and Paul W.H.I. Parren. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.